This study tests a new drug called WTX-330 for people with serious types of cancer, like advanced solid tumors or non-Hodgkin lymphoma. These are cancers that have spread to other parts of the body (metastatic) or don't respond to regular treatments. The study is Phase 1, meaning it's the first time humans are trying this drug to see if it's safe and helps with cancer. Open-label means both the doctors and the patients know what treatment is being given. The drug is a special form of IL-12, a protein that might help the immune system fight cancer. The study will check for side effects and how well the drug works. People who want to join must be 18 or older and fit certain health criteria. However, you can't join if you have other health issues like another cancer, brain problems, or certain infections.

• Study involves regular visits for treatment and check-ups.
• You must agree to use birth control during and after the study.
• Previous treatments and current health conditions will be reviewed closely.